Mortality Trends, Outcomes, and Predictors of Portal Vein Thrombosis in Acute Pancreatitis Patients: A Propensity-Matched National Study.


Journal

Digestive diseases and sciences
ISSN: 1573-2568
Titre abrégé: Dig Dis Sci
Pays: United States
ID NLM: 7902782

Informations de publication

Date de publication:
06 2023
Historique:
received: 19 12 2022
accepted: 04 04 2023
medline: 18 5 2023
pubmed: 25 4 2023
entrez: 25 4 2023
Statut: ppublish

Résumé

Portal vein thrombosis (PVT) is a rare complication of acute pancreatitis (AP) and might be associated with worse outcomes. We aimed to study trends, outcomes, and predictors of PVT in AP patients. The National Inpatient Sample database was utilized to identify the adult patients (≥ 18 years) with primary diagnosis of AP from 2004 to 2013 using International Classification of Disease, Ninth Revision. Patients with and without PVT were entered into propensity matching model based on baseline variables. Outcomes were compared between both groups and predictors of PVT in AP were identified. Among the total of 2,389,337 AP cases, 7046 (0.3%) had associated PVT. The overall mortality of AP decreased throughout the study period (p trend ≤ 0.0001), whereas mortality of AP with PVT remained stable (1-5.7%, p trend = 0.3). After propensity matching, AP patients with PVT patients had significantly higher in-hospital mortality (3.3% vs. 1.2%), AKI (13.4% vs. 7.7%), shock (6.9% vs. 2.5%), and need for mechanical ventilation (9.2% vs. 2.5%) along with mean higher cost of hospitalization and length of stay (p < 0.001 for all). Lower age (Odd ratio [OR] 0.99), female (OR 0.75), and gallstone pancreatitis (OR 0.79) were negative predictors, whereas alcoholic pancreatitis (OR 1.51), cirrhosis (OR 2.19), CCI > 2 (OR 1.81), and chronic pancreatitis (OR 2.28) were positive predictors of PVT (p < 0.001 for all) in AP patients. PVT in AP is associated with significantly higher risk of death, AKI, shock, and need for mechanical ventilation. Chronic and alcoholic pancreatitis is associated with higher risk of PVT in AP.

Sections du résumé

BACKGROUND
Portal vein thrombosis (PVT) is a rare complication of acute pancreatitis (AP) and might be associated with worse outcomes. We aimed to study trends, outcomes, and predictors of PVT in AP patients.
METHODS
The National Inpatient Sample database was utilized to identify the adult patients (≥ 18 years) with primary diagnosis of AP from 2004 to 2013 using International Classification of Disease, Ninth Revision. Patients with and without PVT were entered into propensity matching model based on baseline variables. Outcomes were compared between both groups and predictors of PVT in AP were identified.
RESULTS
Among the total of 2,389,337 AP cases, 7046 (0.3%) had associated PVT. The overall mortality of AP decreased throughout the study period (p trend ≤ 0.0001), whereas mortality of AP with PVT remained stable (1-5.7%, p trend = 0.3). After propensity matching, AP patients with PVT patients had significantly higher in-hospital mortality (3.3% vs. 1.2%), AKI (13.4% vs. 7.7%), shock (6.9% vs. 2.5%), and need for mechanical ventilation (9.2% vs. 2.5%) along with mean higher cost of hospitalization and length of stay (p < 0.001 for all). Lower age (Odd ratio [OR] 0.99), female (OR 0.75), and gallstone pancreatitis (OR 0.79) were negative predictors, whereas alcoholic pancreatitis (OR 1.51), cirrhosis (OR 2.19), CCI > 2 (OR 1.81), and chronic pancreatitis (OR 2.28) were positive predictors of PVT (p < 0.001 for all) in AP patients.
CONCLUSION
PVT in AP is associated with significantly higher risk of death, AKI, shock, and need for mechanical ventilation. Chronic and alcoholic pancreatitis is associated with higher risk of PVT in AP.

Identifiants

pubmed: 37097368
doi: 10.1007/s10620-023-07945-x
pii: 10.1007/s10620-023-07945-x
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2674-2682

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Peery AF, Crockett SD, Barritt AS et al. Burden of gastrointestinal, liver, and pancreatic diseases in the United States. Gastroenterology 2015;149:1731-1741 e3.
doi: 10.1053/j.gastro.2015.08.045 pubmed: 26327134
Papachristou GI, Muddana V, Yadav D et al. Comparison of BISAP, Ranson’s, APACHE-II, and CTSI scores in predicting organ failure, complications, and mortality in acute pancreatitis. Am J Gastroenterol 2010;105:435–441 (quiz 442).
doi: 10.1038/ajg.2009.622 pubmed: 19861954
Petrov MS, Shanbhag S, Chakraborty M et al. Organ failure and infection of pancreatic necrosis as determinants of mortality in patients with acute pancreatitis. Gastroenterology 2010;139:813–820.
doi: 10.1053/j.gastro.2010.06.010 pubmed: 20540942
Easler J, Muddana V, Furlan A et al. Portosplenomesenteric venous thrombosis in patients with acute pancreatitis is associated with pancreatic necrosis and usually has a benign course. Clin Gastroenterol Hepatol 2014;12:854–862.
doi: 10.1016/j.cgh.2013.09.068 pubmed: 24161350
Valla DC, Condat B. Portal vein thrombosis in adults: pathophysiology, pathogenesis and management. J Hepatol 2000;32:865–871.
doi: 10.1016/S0168-8278(00)80259-7 pubmed: 10845677
Rebours V, Boudaoud L, Vullierme MP et al. Extrahepatic portal venous system thrombosis in recurrent acute and chronic alcoholic pancreatitis is caused by local inflammation and not thrombophilia. Am J Gastroenterol 2012;107:1579–1585.
doi: 10.1038/ajg.2012.231 pubmed: 22825367
Mendelson RM, Anderson J, Marshall M et al. Vascular complications of pancreatitis. ANZ J Surg 2005;75:1073–1079.
doi: 10.1111/j.1445-2197.2005.03607.x pubmed: 16398814
Bernades P, Baetz A, Levy P et al. Splenic and portal venous obstruction in chronic pancreatitis: a prospective longitudinal study of a medical-surgical series of 266 patients. Dig Dis Sci 1992;37:340–346.
doi: 10.1007/BF01307725 pubmed: 1735356
Xu W, Qi X, Chen J et al. Prevalence of splanchnic vein thrombosis in pancreatitis: a systematic review and meta-analysis of observational studies. Gastroenterol Res Pract 2015;2015:245460.
doi: 10.1155/2015/245460 pubmed: 26451142 pmcid: 4584234
Dorffel T, Wruck T, Ruckert RI et al. Vascular complications in acute pancreatitis assessed by color duplex ultrasonography. Pancreas 2000;21:126–133.
doi: 10.1097/00006676-200008000-00004 pubmed: 10975705
Gonzelez HJ, Sahay SJ, Samadi B et al. Splanchnic vein thrombosis in severe acute pancreatitis: a 2-year, single-institution experience. HPB (Oxford) 2011;13:860–864.
doi: 10.1111/j.1477-2574.2011.00392.x pubmed: 22081920
Harris S, Nadkarni NA, Naina HV et al. Splanchnic vein thrombosis in acute pancreatitis: a single-center experience. Pancreas 2013;42:1251–1254.
doi: 10.1097/MPA.0b013e3182968ff5 pubmed: 24152951
Mortele KJ, Mergo PJ, Taylor HM et al. Peripancreatic vascular abnormalities complicating acute pancreatitis: contrast-enhanced helical CT findings. Eur J Radiol 2004;52:67–72.
doi: 10.1016/j.ejrad.2003.10.006 pubmed: 15380848
Forsmark CE, Vege SS, Wilcox CM. Acute pancreatitis. N Engl J Med 2016;375:1972–1981.
doi: 10.1056/NEJMra1505202 pubmed: 27959604
Tenner S, Baillie J, DeWitt J et al. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol 2013;108:1400–15 1416.
doi: 10.1038/ajg.2013.218 pubmed: 23896955
Steer ML. Pathogenesis of acute pancreatitis. Digestion 1997;58:46–49.
doi: 10.1159/000201525 pubmed: 9225091
Amitrano L, Guardascione MA, Brancaccio V et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol 2004;40:736–741.
doi: 10.1016/j.jhep.2004.01.001 pubmed: 15094219
Schoots IG, Koffeman GI, Legemate DA et al. Systematic review of survival after acute mesenteric ischaemia according to disease aetiology. Br J Surg 2004;91:17–27.
doi: 10.1002/bjs.4459 pubmed: 14716789
Singh VK, Wu BU, Bollen TL et al. A prospective evaluation of the bedside index for severity in acute pancreatitis score in assessing mortality and intermediate markers of severity in acute pancreatitis. Am J Gastroenterol 2009;104:966–971.
doi: 10.1038/ajg.2009.28 pubmed: 19293787
Wadhwa V, Patwardhan S, Garg SK et al. Health care utilization and costs associated with acute pancreatitis. Pancreas 2017;46:410–415.
doi: 10.1097/MPA.0000000000000755 pubmed: 28099261
Pancreas Study Group CSoGCMA. Practice guidance for diagnosis and treatment of pancreatitis-related splanchnic vein thrombosis (Shenyang, 2020). J Dig Dis 2021;22:2–8.
doi: 10.1111/1751-2980.12962
Intagliata NM, Caldwell SH, Tripodi A. Diagnosis, development, and treatment of portal vein thrombosis in patients with and without cirrhosis. Gastroenterology 2019;156:1582-1599 e1.
doi: 10.1053/j.gastro.2019.01.265 pubmed: 30771355
Anand A, Gunjan D, Agarwal S et al. Vascular complications of chronic pancreatitis: A tertiary center experience. Pancreatology 2020;20:1085–1091.
doi: 10.1016/j.pan.2020.07.005 pubmed: 32800648
Banks PA, Freeman ML, Practice Parameters Committee of the American College of Gastroenterology. Practice guidelines in acute pancreatitis. Am J Gastroenterol 2006;101:2379–2400.
doi: 10.1111/j.1572-0241.2006.00856.x pubmed: 17032204
Ranson JH. Etiological and prognostic factors in human acute pancreatitis: a review. Am J Gastroenterol 1982;77:633–638.
pubmed: 7051819

Auteurs

Rajat Garg (R)

Department of Gastroenterology, Hepatology and Nutrition, Digestive Diseases and Surgery Institute, Cleveland Clinic, Cleveland, OH, USA. gargr@ccf.org.

Abdul Mohammed (A)

Department of Gastroenterology and Hepatology, Advent Health, Orlando, FL, USA.

Amandeep Singh (A)

Department of Gastroenterology, Hepatology and Nutrition, Digestive Diseases and Surgery Institute, Cleveland Clinic, Cleveland, OH, USA.

Hassan Siddiki (H)

Department of Gastroenterology, Hepatology and Nutrition, Digestive Diseases and Surgery Institute, Cleveland Clinic, Cleveland, OH, USA.

Amit Bhatt (A)

Department of Gastroenterology, Hepatology and Nutrition, Digestive Diseases and Surgery Institute, Cleveland Clinic, Cleveland, OH, USA.

Madhusudhan R Sanaka (MR)

Department of Gastroenterology, Hepatology and Nutrition, Digestive Diseases and Surgery Institute, Cleveland Clinic, Cleveland, OH, USA.

Sunguk Jang (S)

Department of Gastroenterology, Hepatology and Nutrition, Digestive Diseases and Surgery Institute, Cleveland Clinic, Cleveland, OH, USA.

C Roberto Simons-Linares (CR)

Department of Gastroenterology, Hepatology and Nutrition, Digestive Diseases and Surgery Institute, Cleveland Clinic, Cleveland, OH, USA.

Tyler Stevens (T)

Department of Gastroenterology, Hepatology and Nutrition, Digestive Diseases and Surgery Institute, Cleveland Clinic, Cleveland, OH, USA.

John Vargo (J)

Department of Gastroenterology, Hepatology and Nutrition, Digestive Diseases and Surgery Institute, Cleveland Clinic, Cleveland, OH, USA.

Prabhleen Chahal (P)

Department of Gastroenterology, Hepatology and Nutrition, Digestive Diseases and Surgery Institute, Cleveland Clinic, Cleveland, OH, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH